To further explore the gene regulatory mechanisms underlying the downregulation of HSP70 in drug-resistant prostate cancer cells, we performed RNA sequencing using C4–2B MDVR cells treated with JG98 to identify the gene programs affected by the treatment. This evidence concerns the gene HSPA1A and prostate cancer.